Model 1 (within 60 days) | Model 2 (within 90 days) | Model 3 (within 120 days) | ||||
---|---|---|---|---|---|---|
Adjusted hazard ratio (95% CI) | P | Adjusted hazard ratio (95% CI) | P | Adjusted hazard ratio (95% CI) | P | |
Age, years | 1.050 (1.007–1.094) | 0.021 | 1.044 (1.005–1.086) | 0.028 | 1.040 (1.001–1.081) | 0.047 |
Performance status | 1.872 (1.213–2.890) | 0.005 | 1.611 (1.029–2.520) | 0.037 | 1.757 (1.136–2.719) | 0.011 |
Chronic kidney disease | 3.125 (1.746–5.593) | < 0.001 | 3.389 (1.811–6.343) | < 0.001 | 2.499 (1.362–4.587) | 0.003 |
C-reactive protein (mg/dL) | 0.959 (0.925–0.995) | 0.025 | 0.939 (0.904–0.975) | 0.001 | 0.955 (0.919–0.994) | 0.023 |
Albumin (g/dL) | 0.161 (0.085–0.307) | < 0.001 | 0.194 (0.101–0.372) | < 0.001 | 0.212 (0.109–0.412) | < 0.001 |
Conversion within 60 days | n.s. | n.s. | n.a. | n.a. | n.a. | n.a. |
Conversion within 90 days | n.a. | n.a. | 0.424 (0.252–0.712) | 0.001 | n.a. | n.a. |
Conversion within 120 days | n.a. | n.a. | n.a. | n.a. | 0.333 (0.195–0.570) | < 0.001 |